New experimental drug begins human testing for autoimmune diseases
Disease control
Recruiting now
This is the first human study testing an experimental drug called CPTX2309. Researchers want to see if it's safe and how the body handles it in healthy volunteers and people with moderate to severe rheumatoid arthritis or lupus. The study will test different doses given through a…
Phase: PHASE1 • Sponsor: Capstan Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC